Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drug Development Projects to Benefit from Enhanced Liver Toxicity Data

By LabMedica International staff writers
Posted on 17 Mar 2011
An advanced cartridge add-on package for cell-cytometry imaging provides dedicated, real-time data on the toxic effects of potential candidate drug compounds on liver cells.

The Thermo Fisher Scientific Inc. More...
(Milford, MA, USA) ToxInsight DILI (drug-induced liver injury) Assay Cartridge is a groundbreaking new tool for assessing the liver toxicity risk of chemical compounds.

The DILI Assay Cartridge was designed to be used with the Thermo Scientific ToxInsight IVT image cytometry platform. The powerful analytical and visualization software that powers this add-on module enables the system to identify drug-induced hepatotoxicity by simultaneous detection of multiplexed toxicity biomarkers in single cells. The package includes all the reagents, assay protocols, analysis, and data reporting capabilities needed to profile compounds for hepatotoxicity with high sensitivity and specificity.

The ToxInsight IVT platform makes multiple measurements on each cell, generating a phenotype rather than a single measurement. This automated, bench-top platform is easy to use and provides physiologically relevant toxicity assays early in the drug discovery process, eliminating reliance on late-stage histopathology or animal studies. Furthermore, the ToxInsight IVT platform not only profiles compounds for their toxicity risk, it also determines the mechanism of action of any toxicity detected, enabling researchers to understand rapidly the therapeutic index of a compound series in minutes.

Related Links:

Thermo Fisher Scientific Inc.




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.